LLY vs BAX
By Alex · Tickerpine
Eli Lilly and Company vs Baxter International Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | BAX |
|---|---|---|
| Price | $1,208.12 | $22.04 |
| Market cap | $1.08T | $11.38B |
| P/E ratio | 42.9 | — |
| ROE | 107.46% | -15.01% |
| Profit margin | 34.99% | -9.70% |
| Revenue growth | 55.50% | 2.90% |
| Dividend yield | 0.57% | 0.91% |
| Beta | 0.52 | 0.64 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs BAX in plain English
- LLY is the bigger company — about 94.6× the market cap of BAX.
- LLY earns a higher return on equity (107% vs -15%).
- LLY is growing revenue faster (56% vs 3%).
- BAX has the higher dividend yield (0.91% vs 0.57%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
BAX return calculator
See what $1,000 in Baxter International Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.